欢迎来到艾兰博曼,请 登录 | 立即注册
查看: 1518|回复: 4

【资讯翻译】ACLA Stresses Value of Lab Testing During Breast Cancer Awa...

[复制链接]

10

听众

10

收听

1954

积分

管理员

Rank: 9Rank: 9Rank: 9

积分
1954
发表于 2014-10-14 16:01:34 | 显示全部楼层 |阅读模式
ACLA Stresses Value of Lab Testing During Breast Cancer Awareness Month

One in eight women will be diagnosed with breast cancer in their lifetime, touching the lives of millions of Americans – and many more worldwide. Therefore, the American Clinical Laboratory Association (ACLA) today recognizes Breast Cancer Awareness Month as a time to encourage diagnostic lab testing and early detection as some of the most powerful tools in fighting the disease.

Despite the prevalence of breast cancer, death rates have declined steadily over the past two decades. However, each year over 220,000 women will still be diagnosed with breast cancer and more than 40,000 of those will lose their lives to this pervasive disease. Early detection has played a critical role in reeling back mortality and extending the lives of women, and will continue to be an essential tool in battling breast cancer.

“Breast cancer can often be caught earlier, treated more effectively, and potentially even prevented with the help of laboratory testing,” said ACLA President, Alan Mertz. “Regular doctor visits will provide patients with screening tests that can identify the disease in its earliest stages, when it can be addressed most successfully.”

Some of the most important early identification tools in use today were developed by the clinical lab community. In fact, tests that identify the presence of the hereditary breast cancer gene and predict the effectiveness of chemotherapy and chance of recurrence now exist. The result: earlier, more consistent detection and increasingly effective, personalized treatment options.

Most importantly, though, these tests have saved lives.

“Clinical lab tests are vital, especially for breast cancer patients, as they help provide patients with the opportunity to manage their cancer risks,” said Mertz. “This can make a significant difference not only the health of patients, but for their economic wellbeing.”

A 2009 National Institutes of Health (NIH) study estimated that per-patient costs of breast cancer ranged from $20,000 to $100,000, and today out-of-pocket costs reach even higher. Additionally, the NIH estimates that the disease costs Americans a total of $16.5 billion each year. Cost-effective clinical testing, therefore, can save patients – and the American healthcare system – millions of dollars.

Ultimately, Breast Cancer Awareness Month marks a crucial moment to consider all aspects of care, and the future of breast cancer treatment.

“Breast Cancer Awareness Month is a ideal time for women, their families, and their care providers to be aware of the best medical and scientific tools available,” said Mertz. “As we make strides in clinical testing, we make strides in making breast cancer a thing of the past. And that leads to a better future for all.”



0

听众

0

收听

23

积分

新手上路

Rank: 1

积分
23
发表于 2014-10-14 16:43:25 | 显示全部楼层
我认领了哦

0

听众

0

收听

23

积分

新手上路

Rank: 1

积分
23
发表于 2014-10-15 11:32:26 | 显示全部楼层
放弃认领喽,大家快来认领啦

0

听众

0

收听

232

积分

中级会员

Rank: 3Rank: 3

积分
232
发表于 2014-10-15 15:27:56 | 显示全部楼层
看来还是我最闲。。。我领了!

0

听众

0

收听

232

积分

中级会员

Rank: 3Rank: 3

积分
232
发表于 2014-10-15 15:28:13 | 显示全部楼层
ACLA Stresses Value of Lab Testing During Breast Cancer Awareness Month
ACLA在乳腺癌宣传月期间强调实验室检测的价值
八分之一的女性在一生中会被诊断出乳腺癌,这个数据让数百万美国人以及更多的全世界人民感到震惊。因此,今天美国临床实验室协会(ACLA)认为乳腺癌宣传月是促进诊断实验室检测和早期发现作为对抗疾病的强有力武器的一个契机。
尽管在过去的20年里乳腺癌越来越普遍,但死亡率却稳步下降。然而,每年依然有超过22万女性被诊断出乳腺癌,而其中超过4万则由于这普遍存在的疾病失去生命。在降低死亡率和延长女性生命的手段中,早期发现扮演了非常重要的作用。它将成为对抗乳腺癌的一个基本手段。
“在实验室检测的帮助下,乳腺癌常常可以更早被发现,更有效地治疗甚至有可能预防。”ACLA主席Alan Mertz先生说到,“医生定期巡诊可以帮助病人进行筛查,这样可以在疾病最早期的时候确诊,在这个阶段能最成功地解决疾病。”
有些现今在用的最重要的早期诊断工具是临床实验室团体开发的。事实上,现在鉴定遗传性乳腺癌基因以及预测化疗疗效和复发概率的检测都已经有了。这些检测导致的结果就是更早,更一致的发现疾病以及越来越有效率的、个人化的治疗机会。
    然而更重要的是,这些检测拯救生命。
    “临床实验室检测是至关重要的,特别是对于乳腺癌患者来说,因为它们为患者提供了控制癌症风险的机会。”Mertz先生说,“这不仅对患者的健康,也对她们的经济利益造成明显差别。”
一项2009年美国国家卫生研究院(NIH)的研究估计,每个乳腺癌患者的诊疗费用从两万美元到十万美元不等,而如今实际支付费用甚至会更高。此外,NIH估计这个疾病每年将花费美国人民总计16.5亿美元。因此,高性价比的临床检测每年可以为病人以及美国医疗系统节约数百万美元。
    最后,乳腺癌宣传月标志着一个考虑到诊疗的方方面面以及乳腺癌治疗未来的关键时刻来临了。
    “乳腺癌宣传月,对于女性以及她们的家庭和为她们提供照顾的机构来说是一个认识最好最科学的工具的理想时机。”Mertz先生说,“当我们在临床试验中取得进步,我们就在将乳腺癌成为一个历史的工作中取得进步,这将导致一个更美好的未来。”
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

© 2013 艾兰博曼 All Rights Reserved.
( 浙ICP备07020270号-8 )
 
快速回复 返回顶部 返回列表